Source: Global Legal Chronicle

Proteros: Inflexion's Minority Investment in Proteros

Hengeler Mueller advised Proteros' majority shareholder on the transaction. Proteros biostructures GmbH, a leading Germany-based contract research organisation focused on early-stage drug discovery, has won a [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Torsten Neuefeind's photo - Co-Founder & CEO of Proteros

Co-Founder & CEO

Torsten Neuefeind

CEO Approval Rating

85/100

Read more